Literature DB >> 23612617

Morphological changes of the pancreas in course of acute pancreatitis during treatment with Ulinastatin.

Grzegorz Wallner, Michał Solecki, Ryszard Ziemiakowicz, Grzegorz Ćwik, Przemysław Dyndor, Ryszard Maciejewski.   

Abstract

UNLABELLED: Acute pancreatitis is a severe clinical conditio that causes significant mortality in patients. Since we do not have at the moment effective causal treatment research on the use of pro tease inhibitors can produce tangible benefits. In view of the growing number of cases and high mortality in severe AP with one hand, and the lack of a usal treatment research efforts undertaken to search for effective drugs for this disease seem to have deep reasons. AIM OF THE STUDY: was to determine the histopathological changes in the pancreas in the treatment of acute pancreatitis with Ulinastatin.
MATERIAL AND METHODS: The study was conducted in male Wistar rats weighing 250-300 grams. 150 individuals were used for the experiment, 60 of them were treated with Ulinastatin. Experimental acute pancreatitis was induced by the model proposed by Aho and Henckel using sodium taurocholate. Ulinastatin dose numer depended on the duration of the experiment. For histopathological examination pancreatic fragments weighing approximately 1 g each were taken. Assessment and documentation of histopathological preparations were made by light microscopy.
RESULTS: Evaluation of the histological preparations of various time groups showed significantly improved results after application of Ulinastatin, depending on the duration of the inflammation and the number of doses of the drug.
CONCLUSIONS: Application for the treatment of UTI leads to inhibition of the inflammatory process at the stage of pancreatic edema and in cases of severe necrotizing course limits the progression of the disease which gives grounds for its clinical use in humans.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23612617     DOI: 10.2478/pjs-2013-0020

Source DB:  PubMed          Journal:  Pol Przegl Chir        ISSN: 0032-373X


  6 in total

1.  Ulinastatin enhances the therapeutic effect of intraperitoneal lavage on severe acute pancreatitis in rats.

Authors:  Cong Feng; Xuan Su; L I Chen; Xuan Zhou; Bei Li; Li-Li Wang; Fa-Qin Lv; Tan-Shi Li
Journal:  Exp Ther Med       Date:  2015-03-09       Impact factor: 2.447

2.  Ulinastatin plus biapenem for severe pneumonia in the elderly and its influence on pulmonary function and inflammatory cytokines.

Authors:  Rui Zhang; Jitao Ma; Pengxiao Zheng; Ruirui Zheng; Xu Meng; Yinjia Wang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Ulinastatin in the Management of Severe Acute Alcoholic Pancreatitis: A Case Series.

Authors:  Niraj Kumar Keyal; Amit Singh; Abishek Pokhrel; Amid Bhujel; Rupesh Kumar Chaurasia
Journal:  JNMA J Nepal Med Assoc       Date:  2021-12-11       Impact factor: 0.556

4.  Protective effect of ulinastatin on severe pulmonary infection under immunosuppression and its molecular mechanism.

Authors:  Wenshuai Liu; Guozhong Pang; Shengyan Wang; Aiqin Sun
Journal:  Exp Ther Med       Date:  2017-08-22       Impact factor: 2.447

5.  Ulinastatin ameliorates tissue damage of severe acute pancreatitis through modulating regulatory T cells.

Authors:  Yu Pan; Haizong Fang; Fengchun Lu; Minggui Pan; Fei Chen; Ping Xiong; Yi Yao; Heguang Huang
Journal:  J Inflamm (Lond)       Date:  2017-03-20       Impact factor: 4.981

6.  Effect of peritoneal lavage with ulinastatin on the expression of NF-κB and TNF-α in multiple organs of rats with severe acute pancreatitis.

Authors:  Cong Feng; Bei Li; Li-Li Wang; L I Chen; Xuan Zhou; Fa-Qin Lv; Tan-Shi Li
Journal:  Exp Ther Med       Date:  2015-10-15       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.